Theratechnologies to Announce Second Quarter 2024 Financial Results and Provide Business Update

TheratechnologiesTheratechnologies

Theratechnologies

MONTREAL, June 26, 2024 (GLOBE NEWSWIRE) — Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and commercialization of innovative therapies, today announced the Company will report financial results and provide a business update for its second quarter ended May 31, 2024, on Wednesday, July 10 at 8:30 a.m. ET.

The call will be hosted by Paul Lévesque, President and Chief Executive Officer. He will be joined by other members of the management team, including Philippe Dubuc, Senior Vice President and Chief Financial Officer, Christian Marsolais, Ph.D., Senior Vice President and Chief Medical Officer and John Leasure, Global Commercial Officer who will be available to answer questions from participants following prepared remarks.

Participants are encouraged to join the call at least ten minutes in advance to secure access. Conference call dial-in and replay information can be found below.

CONFERENCE CALL INFORMATION

Conference Call Date

July 10, 2024

Conference Call Time

8:30 a.m. ET

Webcast link

https://edge.media-server.com/mmc/p/4mkgkywo

Dial in

1-888-513-4119 (toll free) or 1-412-902-6615 (international)

Access Code

0474907

CONFERENCE CALL REPLAY

Toll Free

1-877-344-7529 (US) / 1-855-669-9658 (Canada)

International Toll

1-412-317-0088

Replay Access Code

4477930

Replay End Date

July 17, 2024

To access the replay using an international dial-in number, please select this link:
https://services.choruscall.com/ccforms/replay.html

 

An archived webcast will also be available on the Company’s Investor Relations website under ‘Past Events’.

About Theratechnologies

Theratechnologies (TSX: TH) (NASDAQ: THTX) is a biopharmaceutical company focused on the development and commercialization of innovative therapies addressing unmet medical needs. Further information about Theratechnologies is available on the Company’s website at www.theratech.com, on SEDAR+ at www.sedarplus.ca and on EDGAR at www.sec.gov. Follow Theratechnologies on Linkedin and X (formerly Twitter).

Contacts:

Investor inquiries:
Philippe Dubuc
Senior Vice President and Chief Financial Officer
[email protected]
438-315-6608

Media inquiries:
Julie Schneiderman
Senior Director, Communications & Corporate Affairs
[email protected]
1-514-336-7800

link